Bicycle Therapeutics plc Property, Plant and Equipment, Gross
Bicycle Therapeutics plc (BCYC) had Property, Plant and Equipment, Gross of $28.19 million as of 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Balance Sheet › Assets › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-08-06
- 2024-06-30: Property, Plant and Equipment, Gross $28.19M.
- 2024-03-31: Property, Plant and Equipment, Gross $27.73M.
- 2023-12-31: Property, Plant and Equipment, Gross $27.91M.
- 2023-09-30: Property, Plant and Equipment, Gross $26.99M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2024-06-30 | $28.19M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $27.73M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $27.91M 10-Q · filed 2024-08-06 |
| 2023-09-30 | $26.99M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $28.01M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $27.02M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $26.97M 10-K · filed 2024-02-20 |
| 2022-09-30 | $22.24M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $22.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $13.83M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.92M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.17M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.85M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.75M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.35M 10-K · filed 2022-03-01 |
| 2020-09-30 | $5.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.23M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $5.03M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.97M 10-K · filed 2021-03-11 |
| 2019-09-30 | $4.41M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.37M 10-Q · filed 2019-08-08 |
| 2018-12-31 | $3.75M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |